Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go.
De Maria Marchiano R, Di Sante G, Piro G, Carbone C, Tortora G, Boldrini L, Pietragalla A, Daniele G, Tredicine M, Cesario A, Valentini V, Gallo D, Babini G, D'Oria M, Scambia G. De Maria Marchiano R, et al. Among authors: daniele g. J Pers Med. 2021 Mar 18;11(3):216. doi: 10.3390/jpm11030216. J Pers Med. 2021. PMID: 33803592 Free PMC article. Review.
Strategies for multiple signalling inhibition.
Tortora G, Bianco R, Daniele G. Tortora G, et al. Among authors: daniele g. J Chemother. 2004 Nov;16 Suppl 4:41-3. doi: 10.1179/joc.2004.16.Supplement-1.41. J Chemother. 2004. PMID: 15688608 Review.
[New frontiers in cancer treatment].
Tortora G, Daniele G. Tortora G, et al. Among authors: daniele g. Recenti Prog Med. 2006 Dec;97(12):781-6. Recenti Prog Med. 2006. PMID: 17252737 Review. Italian.
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer.
Lorusso D, Ceni V, Muratore M, Salutari V, Nero C, Pietragalla A, Ciccarone F, Carbone V, Daniele G, Scambia G. Lorusso D, et al. Among authors: daniele g. Expert Opin Emerg Drugs. 2020 Dec;25(4):445-453. doi: 10.1080/14728214.2020.1836155. Epub 2020 Oct 20. Expert Opin Emerg Drugs. 2020. PMID: 33040627 Review.
Newly diagnosed ovarian cancer: Which first-line treatment?
Lorusso D, Ceni V, Daniele G, Salutari V, Pietragalla A, Muratore M, Nero C, Ciccarone F, Scambia G. Lorusso D, et al. Among authors: daniele g. Cancer Treat Rev. 2020 Dec;91:102111. doi: 10.1016/j.ctrv.2020.102111. Epub 2020 Oct 9. Cancer Treat Rev. 2020. PMID: 33068886 Review.
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer.
Pietragalla A, Duranti S, Daniele G, Nero C, Ciccarone F, Lorusso D, Fagotti A, Scambia G. Pietragalla A, et al. Among authors: daniele g. Expert Opin Investig Drugs. 2021 Feb;30(2):103-110. doi: 10.1080/13543784.2021.1868436. Epub 2021 Jan 11. Expert Opin Investig Drugs. 2021. PMID: 33423551 Review.
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital.
Cesario A, Simone I, Paris I, Boldrini L, Orlandi A, Franceschini G, Lococo F, Bria E, Magno S, Mulè A, Santoro A, Damiani A, Bianchi D, Picchi D, Rasi G, Daniele G, Fabi A, Sergi P, Tortora G, Masetti R, Valentini V, D'Oria M, Scambia G. Cesario A, et al. Among authors: daniele g. J Pers Med. 2021 Mar 27;11(4):244. doi: 10.3390/jpm11040244. J Pers Med. 2021. PMID: 33801668 Free PMC article.
285 results